...
机译:患者急性肾损伤在住院期间继续对肾素 - 血管紧张素系统阻滞剂
Pharmaceutical Care Department King Abdulaziz Medical City;
Section of Nephrology Stratton VA Medical Center;
Department of Preventive Medicine The University of Tennessee Health Science Center;
Department of Clinical Pharmacy Methodist University Hospital;
Department of Preventive Medicine The University of Tennessee Health Science Center;
Department of Clinical Pharmacy Methodist University Hospital;
Department of Clinical Pharmacy The University of Tennessee Health Science Center;
Acute kidney injury; Angiotensin-converting enzyme inhibitors; Angiotensin receptor antagonists; Inpatient; Risk factors;
机译:患者急性肾损伤在住院期间继续对肾素 - 血管紧张素系统阻滞剂
机译:急性肾脏损伤在患有确诊Covid-19患者的案例系列(2019年冠状病毒疾病):血管紧张素转换酶2和肾素 - 血管紧张素系统封锁的作用
机译:静脉内(IV)对比,肾素血管紧张素醛固酮系统阻滞(RAASB)与利尿剂和急性肾损伤(AKI)以及住院患者的死亡率
机译:重症监护病房急性肾损伤住院患者尿液cofilin-1的评估
机译:Covid-19住院患者的急性肾脏损伤和恢复预测
机译:肾素-血管紧张素系统阻滞剂治疗的急性失代偿性心力衰竭和肾功能不全患者的长期死亡率和频繁的再次住院治疗
机译:急性肾脏损伤在患有确诊Covid-19患者的案例系列(2019年冠状病毒疾病):血管紧张素转换酶2和肾素 - 血管紧张素系统封锁的作用